Mark Allen
- Hepatology top 5%
- Oncology top 5%
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 7
-
- Advanced Breast Cancer Therapies 5
- Pharmaceutical Science top 5%
-
- Breast Cancer Treatment Studies 7
-
- Advanced Chemical Physics Studies 6
- Spectroscopy and Quantum Chemical Studies 4
-
- Pediatric Hepatobiliary Diseases and Treatments 3
- Co-authors
- David J. TozerThomas J. BorodyJohnson L. ThistleDavid CunninghamMark HillNicholas F. LaRussoThomas F. BugliosiGerald R. May
- Journals
- British Journal of Cancer (5 papers)Annals of Oncology (4 papers)The Journal of Chemical Physics (3 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Mark Allen
43 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 138
- Hepatology 166
- Oncology 540
- Pulmonary and Respiratory Medicine 441
- Pharmaceutical Science 81
- Physical and Theoretical Chemistry 118
Countries citing papers authored by Mark Allen
This map shows the geographic impact of Mark Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Allen more than expected).
Fields of papers citing papers by Mark Allen
This network shows the impact of papers produced by Mark Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Allen. The network helps show where Mark Allen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Allen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 5 | |
| 3 | 2021 | 45 | |
| 4 | 2020 | 16 | |
| 5 | 2018 | 5 | |
| 6 | 2017 | 1 | |
| 7 | 2011 | 20 | |
| 8 | 2010 | 8 | |
| 9 | 2009 | 33 | |
| 10 | 2008 | 8 | |
| 11 | 2004 | 99 | |
| 12 | 2003 | 6 | |
| 13 | 2003 | 2 | |
| 14 | 2003 | 65 | |
| 15 | 2003 | 2 | |
| 16 | 2002 | 134 | |
| 17 | 1997 | 2 | |
| 18 | 1991 | 15 | |
| 19 | 1989 | 140 | |
| 20 | 1987 | 16 |
About Mark Allen
Mark Allen is a scholar working on Oncology, Cancer Research, Complementary and Manual Therapy, Pulmonary and Respiratory Medicine and Genetics, having authored 46 papers that have together received 1.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Breast Cancer Treatment Studies (7 papers), Advanced Chemical Physics Studies (6 papers), Advanced Breast Cancer Therapies (5 papers), Spectroscopy and Quantum Chemical Studies (4 papers) and Pediatric Hepatobiliary Diseases and Treatments (3 papers). The work is most often cited by research in Hepatology (166 citations), Oncology (540 citations), Pulmonary and Respiratory Medicine (441 citations), Pharmaceutical Science (81 citations) and Physical and Theoretical Chemistry (118 citations). Mark Allen has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include David J. Tozer, Thomas J. Borody, Johnson L. Thistle, David Cunningham, Mark Hill, Nicholas F. LaRusso, Thomas F. Bugliosi, Gerald R. May, E. S. Horning and C E Dukes. Their work appears in journals such as British Journal of Cancer, Annals of Oncology, The Journal of Chemical Physics, Breast Cancer Research and Treatment and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.